Item Type | Name |
Grant
|
HOST CELL INVASION BY TRYPANOSOMA CRUZI
|
Grant
|
Molecular Analysis of Trypanosome Infection
|
Grant
|
Molecular Analysis of Trypanosome Infection
|
Academic Article
|
Perspectives on the Trypanosoma cruzi-host cell receptor interactions.
|
Academic Article
|
Crystal structures of Trypanosoma brucei sterol 14alpha-demethylase and implications for selective treatment of human infections.
|
Academic Article
|
Gene network analysis during early infection of human coronary artery smooth muscle cells by Trypanosoma cruzi and Its gp83 ligand.
|
Academic Article
|
Structural insights into inhibition of sterol 14alpha-demethylase in the human pathogen Trypanosoma cruzi.
|
Academic Article
|
REGULATION of the EXTRACELLULAR MATRIX INTERACTOME by Trypanosoma cruzi.
|
Academic Article
|
Targeting Trypanosoma cruzi sterol 14a-demethylase (CYP51).
|
Academic Article
|
Novel sterol metabolic network of Trypanosoma brucei procyclic and bloodstream forms.
|
Academic Article
|
Regulation and use of the extracellular matrix by Trypanosoma cruzi during early infection.
|
Academic Article
|
Organocatalytic, enantioselective synthesis of VNI: a robust therapeutic development platform for Chagas, a neglected tropical disease.
|
Academic Article
|
Cellular response to Trypanosoma cruzi infection induces secretion of defensin a-1, which damages the flagellum, neutralizes trypanosome motility, and inhibits infection.
|
Academic Article
|
Thrombospondin-1 interacts with Trypanosoma cruzi surface calreticulin to enhance cellular infection.
|
Academic Article
|
Structural basis for rational design of inhibitors targeting Trypanosoma cruzi sterol 14a-demethylase: two regions of the enzyme molecule potentiate its inhibition.
|
Academic Article
|
Immunization with Hexon modified adenoviral vectors integrated with gp83 epitope provides protection against Trypanosoma cruzi infection.
|
Academic Article
|
VFV as a New Effective CYP51 Structure-Derived Drug Candidate for Chagas Disease and Visceral Leishmaniasis.
|
Academic Article
|
Discovery of an ergosterol-signaling factor that regulates Trypanosoma brucei growth.
|
Academic Article
|
Clinical Candidate VT-1161's Antiparasitic Effect In Vitro, Activity in a Murine Model of Chagas Disease, and Structural Characterization in Complex with the Target Enzyme CYP51 from Trypanosoma cruzi.
|
Academic Article
|
Early Regulation of Profibrotic Genes in Primary Human Cardiac Myocytes by Trypanosoma cruzi.
|
Academic Article
|
Sterol 14a-Demethylase Structure-Based Optimization of Drug Candidates for Human Infections with the Protozoan Trypanosomatidae.
|
Academic Article
|
Phospho-proteomic analysis of primary human colon epithelial cells during the early Trypanosoma cruzi infection phase.
|
Academic Article
|
Successful Aspects of the Coadministration of Sterol 14a-Demethylase Inhibitor VFV and Benznidazole in Experimental Mouse Models of Chagas Disease Caused by the Drug-Resistant Strain of Trypanosoma cruzi.
|
Academic Article
|
Thrombospondin-1 Plays an Essential Role in Yes-Associated Protein Nuclear Translocation during the Early Phase of Trypanosoma cruzi Infection in Heart Endothelial Cells.
|
Academic Article
|
Trypanosoma cruzi uses a 45-kDa mucin for adhesion to mammalian cells.
|
Academic Article
|
Transforming growth factor alpha binds to Trypanosoma cruzi amastigotes to induce signaling and cellular proliferation.
|
Academic Article
|
Silencing of the laminin gamma-1 gene blocks Trypanosoma cruzi infection.
|
Academic Article
|
Human galectin-3 promotes Trypanosoma cruzi adhesion to human coronary artery smooth muscle cells.
|
Academic Article
|
Stable RNA interference of host thrombospondin-1 blocks Trypanosoma cruzi infection.
|
Academic Article
|
Molecular cloning of a Trypanosoma cruzi cell surface casein kinase II substrate, Tc-1, involved in cellular infection.
|
Academic Article
|
Human defensin alpha-1 causes Trypanosoma cruzi membrane pore formation and induces DNA fragmentation, which leads to trypanosome destruction.
|
Academic Article
|
Sterol 14alpha-demethylase as a potential target for antitrypanosomal therapy: enzyme inhibition and parasite cell growth.
|
Academic Article
|
Molecular analysis of early host cell infection by Trypanosoma cruzi.
|
Academic Article
|
CYP51: A major drug target in the cytochrome P450 superfamily.
|
Academic Article
|
Indomethacin amides as a novel molecular scaffold for targeting Trypanosoma cruzi sterol 14alpha-demethylase.
|
Concept
|
Trypanosoma
|
Concept
|
Trypanosoma brucei brucei
|
Concept
|
Trypanosoma cruzi
|
Concept
|
Variant Surface Glycoproteins, Trypanosoma
|
Academic Article
|
Novel mechanism that Trypanosoma cruzi uses to adhere to the extracellular matrix mediated by human galectin-3.
|
Academic Article
|
Fibronectin increases Trypanosoma cruzi amastigote binding to and uptake by murine macrophages and human monocytes.
|
Academic Article
|
Effects of human defensin-a(1)on Trypanosoma cruzi trypomastigotes in vitro.
|
Academic Article
|
Trypanosoma cruzi Modulates PIWI-Interacting RNA Expression in Primary Human Cardiac Myocytes during the Early Phase of Infection.
|
Academic Article
|
Thrombospondin-1 expression and modulation of Wnt and hippo signaling pathways during the early phase of Trypanosoma cruzi infection of heart endothelial cells.
|
Academic Article
|
Trypanosoma cruzi Dysregulates piRNAs Computationally Predicted to Target IL-6 Signaling Molecules During Early Infection of Primary Human Cardiac Fibroblasts.
|